BOSTON (MarketWatch) -- Twelve biotech stocks traded on the NASDAQ market hit
52-week highs on Friday, according to NASDAQ OMX. The list includes Alnylam
Pharmaceuticals , whose stock peaked at $20.17; Amgen Inc. , at $83.09; Ariad
Pharmaceuticals , at $18.83; Array BioPharma , at $4.82; Biogen Idec Inc. , at
$150; Infinity Pharmaceuticals , at $18.30; Ligand Pharmaceuticals , at $19.26;
Medivation Inc. , at $102.87; Quiagen N.V. , at $17.88; Rigel Pharmaceuticals ,
at $11.10; Seattle Genetics Inc. , at $27.72; and Synageva BioPharma Corp. , at
$50.41. |
